Search
Search
Deborah Ristvedt, DO; and Mathew Walker, OD
Show Description +
In this video, Dr. Deborah Ristvedt shares her thoughts on the value of putting time into learning how to do MIGS by reading published studies and speaking with thought leaders and colleagues about their personal experiences. She also shares the key steps to becoming comfortable with working in the angle, from investing time in a dry lab to mastering visualization in the OR. Additionally, Dr. Mathew Walker provides his perspective on the value of earlier surgical intervention and the benefits to the patient.
Posted: 4/18/2022
Deborah Ristvedt, DO; and Mathew Walker, OD
In this video, Dr. Deborah Ristvedt shares her thoughts on the value of putting time into learning how to do MIGS by reading published studies and speaking with thought leaders and colleagues about their personal experiences. She also shares the key steps to becoming comfortable with working in the angle, from investing time in a dry lab to mastering visualization in the OR. Additionally, Dr. Mathew Walker provides his perspective on the value of earlier surgical intervention and the benefits to the patient.
Posted: 4/18/2022
The Crucial Choice in Combating Glaucoma With Interventional Treatment
MIGS Beyond Cataract Surgery: An Interventional Mindset
Nine Reasons Why We Perform MIGS with OMNI
_1657116947.jpg)
MIGS Beyond Cataract Surgery
Spotlight on OMNI in Standalone Procedures
The Benefits of OMNI in Pseudophakic Patients
MIGS Algorithm: Navigating A Myriad of Decisions
The Changing MIGS Landscape
OMNI Surgical System: My First 10 Patients
About Sight Sciences
At Sight Sciences, we are reimagining eyecare with transformative technology and an interventional mindset. We believe interventions should happen sooner to preserve, protect, or restore natural eye function. So, we aim to provide eyecare providers with transformative, clinically-proven therapies that are intuitive, less invasive, and more intelligent. Our mission is clear: to develop transformative, interventional technologies that allow eyecare providers to procedurally elevate the standards of care – empowering people to keep seeing
Explore more at sightsciences.com
Follow Sight Sciences
IMPORTANT PRODUCT INFORMATION:
The OMNI® Surgical System is indicated for canaloplasty (microcatheterization and transluminal viscodilation of Schlemm’s canal) followed by trabeculotomy (cutting of trabecular meshwork) to reduce intraocular pressure in adult patients with primary open-angle glaucoma. Do not use the OMNI® in any situations where the iridocorneal angle is compromised or has been damaged (e.g., from trauma or surgery), since it may not be possible to visualize the angle or to properly pass the microcatheter. Do not use the OMNI® in patients with angle recession; neovascular glaucoma; chronic angle closure; narrow-angle glaucoma; traumatic or malignant glaucoma; or narrow inlet canals with plateau iris. Do not use the OMNI® Surgical System in quadrants with previous MIGS implants. Visit omnisurgical.com/ifu for the indications for use, contraindications, warnings, and potential adverse events.
Doctors are paid consultants of Sight Sciences, Inc.
© 2025 Sight Sciences. Sight Sciences, the Sight Sciences logo, and OMNI are registered trademarks of Sight Sciences. 04/2025 OM-1129-US.v4
_1748562763.jpg?auto=compress,format&w=180)
